US approves Pfizer booster dose for 12-15 year olds

Pfizer vaccine booster dose will be given from the age of 12.

Pfizer vaccine booster dose will be given from the age of 12.

Photo: Chip Somodevilla / Getty Images

The U.S. Food and Drug Administration (FDA) approved this Monday the use of the booster vaccine against COVID-19 from Pfizer / BioNTech for children between 12 and 15 years, considering that the benefits outweigh the risks.

“The benefits of a booster dose of Pfizer / BioNTech to provide continued protection against COVID-19 and the possible associated consequences of hospitalization and death are higher than the potential risks in individuals aged 12-15 years“, Indicated the FDA in a statement.

In addition, the government entity also shortened the minimum time that must pass between the full schedule of the Pfizer vaccine and the booster dose, which will now be only five months, and approved the use of the booster dose in some children between 5 and 11 years with deficiencies in the immune system.

With the current wave of the Omicron variant, it is critical that we continue to take effective preventive measures and lifesaving such as vaccination and booster doses, mask use and social distancing, “said Acting FDA Commissioner Janet Woodcock.

Those over 18 years old can already receive the booster dose of vaccines available for weeks in the US, while boys and girls between the ages of 5 and 11 began receiving their first injections last November.

The United States is experiencing a record of COVID-19 infections with the arrival of the Omicron variant, with about 400,000 a day in the last week.

It may interest you:
FDA authorizes Pfizer pill to treat Covid-19 in high-risk patients
COVID: When will the Pfizer pill that reduces the risk of death and hospitalization be available?
Pfizer states that if your Paxlovid pill is administered within 3 days of the onset of symptoms, it reduces the risk of hospitalization and death by 89%


Spread the love